tm
Seeing Is Believing
tm
Seeing Is Believing
VVOS is currently covered by 2 analysts with an average price target of $1.76. This is a potential upside of $-1.69 (-48.99%) from yesterday's end of day stock price of $3.45.
Vivos Therapeutics 's activity chart (see below) currently has 2 price targets and 5 ratings on display. The stock rating distribution of VVOS is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 75% with an average time for these price targets to be met of 279.5 days.
Highest price target for VVOS is $6, Lowest price target is $6, average price target is $1.76.
Most recent stock forecast was given by SCOTT HENRY from ALLIANCE GLOBAL PARTNERS on 19-Nov-2024. First documented stock forecast 20-May-2022.
Currently out of the existing stock ratings of VVOS, 2 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$6
$2.88 (92.31%)
$8
3 months 8 days ago
(19-Nov-2024)
1/2 (50%)
$3.21 (115.05%)
312
Buy
$2.75
$-0.37 (-11.86%)
1 years 11 months 19 days ago
(08-Mar-2023)
1/1 (100%)
$-6.58 (-70.53%)
247
What is VVOS (Vivos Therapeutics ) average time for price targets to be met?
Which analyst has the current highest performing score on VVOS (Vivos Therapeutics ) with a proven track record?
Which analyst has the current lower performing score on VVOS (Vivos Therapeutics ) with a proven track record?
Which analyst has the most public recommendations on VVOS (Vivos Therapeutics )?
Which analyst is the currently most bullish on VVOS (Vivos Therapeutics )?
Which analyst is the currently most reserved on VVOS (Vivos Therapeutics )?
